Lung squamous cell carcinoma

Product name Lung squamous cell carcinoma
Cat. No. 2880523A
No. of samples 1
Description lung, squamous cell carcinoma
Age/Sex : 70/M
Price 197 EUR
260 USD
170 GBP

Lung squamous cell carcinoma

Product Related Literature

Non-small cell lung cancer (NSCLC) is a type one cell carcinoma, lung cancer, non-small cell lung cancer (SCLC). As a class, compared to small cell carcinoma, NSCLCs are relatively insensitive to chemotherapy. (Adjuvant) surgery (like preoperative chemotherapy) before chemotherapy is used after surgery more and more, if available, and preferably, they are treated with surgical resection for therapeutic purposes. Squamous cell carcinoma, the most common type of NSCLC is a large cell carcinoma and adenocarcinoma, but there are other species of some that occur frequently, all the abnormal histological variants and mixed cell type I can occur in combination.

Sometimes, particularly if it can not be diagnosed (NOS or “not specified”), usually, the term “non-small cell lung cancer,” commonly used. This pathologist is if, you have examined the tissue and malignant cells in a little biopsy samples or cytology most often. Lung cancer is adenocarcinoma NSCLC and majority, and there is almost universally never smokers.

Malignant tumors, it can be seen that elements of NSCLC and SCLC contains relatively infrequently in the lungs. In these cases, it is classified coupled small cell carcinoma of the lung (C-small cell lung cancer), and tumor to be treated as a “pure” (usually) SCLC. Lung cancer is the most common type of lung cancer in (lifetime nonsmokers) “never smokers”. Adenocarcinoma accounts for about 40% of the lung. Historically, adenocarcinoma is about either. Tend to be located in the center more often, been observed in squamous cell carcinoma and peripheral lung small cell lung cancer of the lung often. Interestingly, however, a recent study, lesion shows may be close to unity for squamous cell carcinoma and adenocarcinoma “ratio of the center takes place around” that.

Lung squamous cell carcinoma (SCC), the man is more common than women. Than most types of other lung cancer, it is associated with a history of smoking even more closely. According to a health survey of nurses, the relative risk of SCC, from 20 to 30 years is between those with the previous period of smoking up to about 5.5,1 to 20 years in comparison with the car in any way. If you have a previous period and smoked and 40 about 16 30, relative risk increased to ’40 of about 22 or more.

In most cases, generates a large bronchi center, which transfers the beginning of the development of (hilar node particular) regional lymph nodes are often, but this chest than major other types of lung cancer little delay it generally liver spread on the outside of the. Large tumors, can receive lead to cavitation, the central necrosis. The squamous cell carcinoma often, squamous metaplasia, after years of airway epithelial dysplasia of the bronchi that is converted to the cancer site prior. I can be cancer, abnormal cells are identified by bronchial brushing cytologic smear sputum, or bronchoalveolar lavage fluid sample. However, asymptomatic in X-ray imaging and intraepithelial squamous cell carcinoma can be detected. Finally, it will be the symptoms, when it begins to interfere with the lumen of the bronchus in general, the tumor is large, causing atelectasis distal infection frequently. At the same time, the lesions invade the lungs surrounding material. And minimal residual function only differentiation, because showing the unit cell and keratin pearl squamous cell carcinoma to undifferentiated, histopathology of tumor extent of these.

At present, it is squamous cell carcinoma of the lung recognition (clear cell basal cell papilla, and small cell,) four. Of these embodiments, “is the traditional” small cell differentiation mutant basal cell and there is evidence that may have a poorer prognosis than squamous cell carcinoma. Papillary variant occurs more frequently, bronchial lesions superficial is currently available in a clear cell variant of squamous cell carcinoma mainly data and a little modest good prognosis, consensus has not been reached on the prognosis of clear cell changes in lung cancer. Recently, (Basic Primitives and basal secretion) 4 subtypes mRNA expression have been identified and are well known in the squamous cell carcinoma. Subtypes primitive correlates with poor survival of patients. These subtypes are defined by the formula essential differences to provide a basis for improving the therapeutic research and individual patient outcomes.